Items related to Fragment-Based Drug Discovery: A Practical Approach
Synopsis
Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery.
Fragment-Based Drug Discovery: A Practical Approach is a guide to the techniques and practice of using fragments in drug screening. The emphasis is on practical guidance, with procedures, case studies, practical tips, and contributions from industry. Topics covered include:
- an introduction to fragment based drug discovery, why using fragments is a more efficient process than predominant models, and what it means to have a successful FBDD effort.
- setting up an FBDD project
- library building and production
- NMR in fragment screening and follow up
- application of protein-ligand NOE matching to the rapid evaluation of fragment binding poses
- target immobilized NMR screening: validation and extension to membrane proteins
- in situ fragment-based medicinal chemistry: screening by mass spectrometry
- computational approaches to fragment and substructure discovery and evaluation
- virtual fragment scanning: current trends, applications and web based tools
- fragment-based lead discovery using covalent capture methods
- case study from industry: the identification of high affinity beta-secretase inhibitors using fragment-based lead generation
With contributions from industry experts who have successfully set up an industrial fragment-based research program, Fragment-Based Drug Discovery: A Practical Approach offers essential advice to anyone embarking on drug discovery using fragments and those looking for a new approach to screening for drugs.
"synopsis" may belong to another edition of this title.
About the Author
Edward R. Zartler, Strategy Consultant, Eli Lilly & Co.; Established the Fragment-based Drug Design paradigm at Eli Lilly.
Michael J. Shapiro, Associate Professor of Pharmacy, University of Maryland School of Pharmaceutical Sciences; Industry experience at Lilley, Novartis and Sandoz.
Review
"This is a useful book for readers already familiar with the basic aspects of drug design and discovery." (ChemMedChem, October 2009)
"This book provides an excellent resource for those in pharmaceutical research who are interested in fragment-based drug discovery. Most of the topics are covered in enough detail that this book could be used as a guide for those initiating a program in fragment-based drug discovery." (Journal of the American Chemical Society, April 29, 2009)
"As the authors eloquently state in Chapter 2, 'Where there is a validated target and a will, there is a (drug discovery) way.'" (Journal of Medicinal Chemistry, 2009)
"About this title" may belong to another edition of this title.
- PublisherWiley
- Publication date2008
- ISBN 10 0470058137
- ISBN 13 9780470058138
- BindingHardcover
- LanguageEnglish
- Edition number1
- Number of pages296
- EditorZartler Edward R., Shapiro Michael
Search results for Fragment-Based Drug Discovery: A Practical Approach
Stock Image
Fragment-Based Drug Discovery - A Practical Approach
Seller: Basi6 International, Irving, TX, U.S.A.
Seller rating 5 out of 5 stars
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEJUNE24-96162
Quantity: Over 20 available
Stock Image
Fragment-Based Drug Discovery - A Practical Approach
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABTA-51481
Quantity: 5 available
Seller Image
Fragment-Based Drug Discovery : A Practical Approach
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 4224039-n
Quantity: Over 20 available
Stock Image
Fragment-Based Drug Discovery
Seller: Books Puddle, New York, NY, U.S.A.
Seller rating 4 out of 5 stars
Condition: New. pp. 296. Seller Inventory # 26406625
Quantity: 4 available
Stock Image
Fragment-Based Drug Discovery
Seller: Majestic Books, Hounslow, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. pp. 296. Seller Inventory # 7441342
Quantity: 4 available
Stock Image
Fragment-Based Drug Discovery
Seller: Biblios, Frankfurt am main, HESSE, Germany
Seller rating 5 out of 5 stars
Condition: New. pp. 296. Seller Inventory # 18406635
Quantity: 4 available
Stock Image
Fragment-Based Drug Discovery - A Practical Approach
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 4 out of 5 stars
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # FW-9780470058138
Quantity: 15 available
Seller Image
Fragment-Based Drug Discovery : A Practical Approach
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: As New. Unread book in perfect condition. Seller Inventory # 4224039
Quantity: Over 20 available
Stock Image
Fragment-Based Drug Discovery (Hardcover)
Published by
John Wiley & Sons Inc, New York, 2008
ISBN 10: 0470058137
ISBN 13: 9780470058138
New
Hardcover
First Edition
Seller: Grand Eagle Retail, Fairfield, OH, U.S.A.
Seller rating 5 out of 5 stars
Hardcover. Condition: new. Hardcover. Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery. Fragment-Based Drug Discovery: A Practical Approach is a guide to the techniques and practice of using fragments in drug screening. The emphasis is on practical guidance, with procedures, case studies, practical tips, and contributions from industry. Topics covered include: an introduction to fragment based drug discovery, why using fragments is a more efficient process than predominant models, and what it means to have a successful FBDD effort.setting up an FBDD projectlibrary building and productionNMR in fragment screening and follow up application of protein-ligand NOE matching to the rapid evaluation of fragment binding posestarget immobilized NMR screening: validation and extension to membrane proteinsin situ fragment-based medicinal chemistry: screening by mass spectrometrycomputational approaches to fragment and substructure discovery and evaluationvirtual fragment scanning: current trends, applications and web based toolsfragment-based lead discovery using covalent capture methodscase study from industry: the identification of high affinity beta-secretase inhibitors using fragment-based lead generation With contributions from industry experts who have successfully set up an industrial fragment-based research program, Fragment-Based Drug Discovery: A Practical Approach offers essential advice to anyone embarking on drug discovery using fragments and those looking for a new approach to screening for drugs. Fragment-based drug discovery is a faster, cheaper, smarter way to do drug discovery. Emphasizing practical guidance, with procedures, case studies, practical tips, and contributions from industry, Fragment-Based Drug Discovery is a comprehensive guide to the techniques and practice of using fragments in drug screening. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9780470058138
Quantity: 1 available
Seller Image
Fragment-Based Drug Discovery
Seller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Gebunden. Condition: New. Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that h. Seller Inventory # 556553882
Quantity: Over 20 available